60
Participants
Start Date
September 9, 2021
Primary Completion Date
February 7, 2030
Study Completion Date
December 17, 2030
Apremilast
Participants will receive apremilast orally.
Placebo
Participants will receive the matching placebo orally.
TERMINATED
Centre Hospitalier Universitaire Vaudois, Lausanne
RECRUITING
Agia Sofia Children Hospital, Athens
RECRUITING
Attikon University General Hospital, Athens
RECRUITING
IRCCS Istituto Giannina Gaslini, Genova
RECRUITING
Azienda Socio Sanitaria Territoriale Centro Specialistico Ortopedico Traumatologico Gaetano Pini, Milan
RECRUITING
Hospital Universitario Ramon y Cajal, Madrid
TERMINATED
Hospital Universitario La Paz, Madrid
RECRUITING
Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi, Istanbul
RECRUITING
Istanbul Universitesi Cerrahpasa Tip Fakultesi, Istanbul
RECRUITING
Umraniye Egitim ve Arastirma Hastanesi, Istanbul
RECRUITING
Dokuz Eylul Universitesi Tip Fakultesi Hastanesi, Izmir
RECRUITING
Erciyes Universitesi Tip Fakultesi Hastanesi, Kayseri
RECRUITING
Hospital Universitario Virgen del Rocio, Seville
RECRUITING
Hospital Universitari i Politecnic La Fe, Valencia
RECRUITING
General Hospital of Thessaloniki Ippokrateio, Thessaloniki
RECRUITING
Ospedale Santissima Annunziata, Chieti
RECRUITING
Hospices Civils de Lyon Hopital Femme Mere Enfant, Bron
TERMINATED
Hopital Necker Enfants Malades, Paris
RECRUITING
Hopital Robert Debre, Paris
RECRUITING
Meir Medical Center, Kfar Saba
RECRUITING
IRCCS Ospedale Pediatrico Bambino Gesu, Roma
RECRUITING
Hospital Universitari Vall d Hebron, Barcelona
RECRUITING
Hospital Sant Joan de Deu, Esplugues de Llobregat
RECRUITING
Hacettepe Universitesi Tip Fakultesi Hastanesi, Ankara
TERMINATED
Birmingham Childrens Hospital, Birmingham
RECRUITING
Alder Hey Childrens Hospital, Liverpool
RECRUITING
John Radcliffe Hospital, Oxford
Lead Sponsor
Amgen
INDUSTRY